Mylan Inc $47.21

up +0.98


16/4/2014 08:10 PM  |  NASDAQ : MYL  
Industries : Drugs / Drugs - Generic
Get Trend Analysis Icon Get MYL Trend Analysis - it has outperformed the S&P 500 by 49%

Partner Headlines

  1. UPDATE: Mylan Launches First Generic ORTHO EVRA Patch

    Benzinga
  2. Mylan Launches Generic Lunesta Tablets

    Benzinga
  3. Mylan Says Judge Has Enforced Settlement Deal Between Mylan, Endo Related ...

    Benzinga
  4. Nasdaq Turns Solidly Higher in Volatile Action

    FoxBusiness
  5. Benzinga's Weekend M&A Chatter

    Benzinga
  6. Meda Rejects Mylan's Takeover Proposal

    Benzinga
  7. Meda Rejects Mylan's Bid

    IBD
  8. Mylan Bid Gets Rejected, But Generic-Drugmaker Rises

    IBD
  9. Mid-Afternoon Market Update: Markets Drop, Lead Lower by NASDAQ Momentum ...

    Benzinga
  10. Growth Names Pressured; Nasdaq Gives Up 50-Day Line

    IBD
  11. Mid-Day Market Update: NASDAQ Tumbles 1.8%; SYNNEX Shares Gain After Upbeat ...

    Benzinga
  12. Mylan Rejected In Bid To Acquire Sweden's Meda

    IBD
  13. Mid-Morning Market Update: Markets Mixed; CarMax Results Miss Estimates

    Benzinga
  14. Meda Board Issues Statement Confirming Contact by Mylan, Rejection of Proposal

    Benzinga
  15. Stock Futures Vector Higher; March Payrolls Report Mixed

    IBD
  16. Benzinga's Top #PreMarket Gainers

    Benzinga
  17. Mylan Considering Takeover of Sweden's Meda -FT

    Benzinga
  18. Which Pharmas Can Keep Up Dividend-Buybacks?

    YCharts
  19. Should You Buy Actavis?

    GuruFocus
  20. Horizon Pharma Banks On Two-For-One Arthritis Drugs

    IBD
  21. US Stock Futures Up Ahead Of Jobless Claims, Retail Sales Data

    Benzinga
  22. Pfizer Loses Patent On Celebrex, Plans To Appeal

    IBD
  23. Pfizer Loses Bid to Hold Celebrex Exclusivity to '15

    FoxBusiness
  24. Will Horizon Pharma Spike Again On Quarterly Report?

    IBD
  25. Stock Market Closes Mixed; Ambarella Tops Expectations

    IBD
  26. Stock Market Closes Mixed; Medical Leaders Drop

    IBD
  27. Morgan Stanley is Awaiting Approvals and M&A on Mylan in the Wake of P/E ...

    Benzinga
  28. Mylan guides up, hits new high

    IBD
  29. Nasdaq Scores Another New High; Mylan, Autohome Surge

    IBD
  30. Stocks Extend Gains In Afternoon; Workday Soars 15%

    IBD
  31. Stocks Hitting 52-Week Highs

    Benzinga
  32. Earnings Scheduled For February 27, 2014

    Benzinga
  33. Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest ROE

    Benzinga
  34. Generic-Drug Makers Actavis, Mylan To Report Q4 Soon

    IBD
  35. Wheels Fly Off GM's CEO Pay Story

    FoxBusiness
  36. Scott Black's Top Five Stocks at Year End

    GuruFocus
  37. Actavis, Perrigo Pace Strong Generic Drugs Group

    IBD
  38. Stock Market Closes Mixed; More Medicals Break Out

    IBD
  39. Market Wrap For January 2: Markets Begin 2014 on Negative Note

    Benzinga
  40. Biologic Makers Thwart Generics: Winning Stocks

    YCharts
  41. Drugmaker Aptalis Files For IPO After Overhaul

    IBD
  42. Mylan Acquires Rights to Novel LAMA Respiratory Compound from Pfizer

    Benzinga
  43. Mylan Announces Settlement Agreement for First-to-File Generic Version ...

    Benzinga
  44. Top 4 Stocks In The Drugs-Generic Industry With The Highest Operating Margin

    Benzinga
  45. Investing Metric Beats Dividend Yield, Buybacks

    YCharts
  46. Top 4 Stocks In The Drugs-Generic Industry With The Highest ROA

    Benzinga
  47. Why Pfizer’s Expiring Viagra Patent Hurts Lilly Most

    YCharts
  48. Teva, Mylan Settle Copaxone Patent Litigation in France, UK, Netherlands ...

    Benzinga
  49. Icahn's Buy Into Hologic Welcomed By Wall Street

    IBD
  50. Mylan Announces Pricing of $2.0B of Senior Notes

    Benzinga
Trading Center